KLICHINSKY MICHAEL (Chief Scientific Officer) sold 484.35K shares of CARISMA THERAPEUTICS INC. on the open market
Open‑market sale worth $124.3K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 10/3/2025ACC: 0001104659-25-096740
Officer· Chief Scientific Officer
Since Mar 2023
-484.35K
Net shares
Net seller
$124.3K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
484.35K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−165K
Price / share
$0.26
Trade value
$42.41K
% of position
34.1%
10/1/2025
484.35K→319.35K
Common Stock
Direct
Shares
−200K
Price / share
$0.25
Trade value
$50.86K
% of position
62.6%
10/2/2025
319.35K→119.35K
Common Stock
Direct
Shares
−119.35K
Price / share
$0.26
Trade value
$31.08K
% of position
New position
10/3/2025
119.35K→0.00
Total
Net shares
−484.35K
Net value
-$124.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2025 | S · Sale | −165K | $0.26 | $42.41K | 34.1% | 484.35K | 319.35K |
| Common Stock Direct | 10/2/2025 | S · Sale | −200K | $0.25 | $50.86K | 62.6% | 319.35K | 119.35K |
| Common Stock Direct | 10/3/2025 | S · Sale | −119.35K | $0.26 | $31.08K | New position | 119.35K | 0.00 |
| Total | −484.35K | -$124.34K | ||||||
Derivative Transactions0
No derivative transactions reported